ArticleAbdominal radiology (New York)2026
Integrating B-mode ultrasound radiomics and clinical variables to predict 26-week progression-free survival in advanced hepatocellular carcinoma under targeted immunotherapy.
Xiaolin Chen et al.PubMed ↗Publisher ↗
No numbers read from the abstract.